Alex Carter is a health economist in the Centre for Health Policy at the Institute of Global Health Innovation, Imperial College London.
His research focuses on the economic impact of quality improvement programs in the NHS and draws on methods used for the economic evaluation of health care programs, management and operational research methods. As part of the patient safety program, Alex's PhD aims to assess the economic impact of a nationwide patient safety initiative, the National Reporting and Learning System (or NRLS). His PhD is supervised by Professor the Lord Ara Darzi and Professor Elias Mossialos (LSE/Imperial).
Alex's other academic interests include pharmaceutical economics and policy, the evaluation of eHealth and mobile health technologies, and the economic impact of surgical checklists used in care. Alex also co-leads the 'Health Systems and Policy' and 'Financing Healthcare' modules on the Masters in Health Policy and lectures on both. He also teaches quantitative analysis methods to undergraduate medical students at the Faculty of Medicine at Imperial College.
Prior to joining the Centre, Alex worked in the United States and Europe as a consultant in the pharmaceutical industry and completed his Master's degree in health policy and economics at the London School of Economics and Political Science. He holds a Master's degree in Applied Physiology from King's College London.
NIHR Health Services & Delivery Research (HS&DR) and Health Technology Assessment (HTA) reviewer of mixed-method evaluations, economic evaluation, HTA, policy evaluation
Editorial board - Journal of Hospital Total Quality Management
Deputy academic director (with Professor Elias Mossialos): Advanced Hospital Quality Management in the Big Data Era
A program designed for China's leading hospital executive officers. This two week module provides training on health systems financing and care provision. We explain methods of 'big' data collection and analysis, and use case studies to demonstrate how evidence can be implemented for clinical and non-clinical quality improvement in hospital care delivery.
Module co-leader (with Professor Elias Mossialos): Masters in Health Policy, Imperial College London
Health Systems and Policy
Delivering lectures on policy evaluation and understanding statistics.
Delivering lectures on cost analysis and pharmaceutical economics and policy.
Selected invited talks and media
National Consultative Meeting for Finalization of 5-year IHR-GHSA Roadmap, Islamabad, Pakistan
Talk entitled: Health investment, planning and costing process
Strategic partnership for country planning workshop for post Joint External Evaluation (JEE) activities, Dar es Salaam, Tanzania
Talk entitled: A rapid review of planning and costing tools for Joint External Evaluations & Progress against the International Health Regulation (2005)
The 2016 Summit on China Hospital Development, Hangzhou, China
Talk entitled: Patient centred care integration in the big data era: models and methods for technological and sociological reform
Royal Society of Medicine (London): President's Day 2016: Making surgery safer through teams, training and technology
Talk entitled: What is the cost of surgical error? An economist's perspective
Health Economics Global Congress (London) - pharmaceutical industry
Talk entitled: The System’s Outlook: The Global Business in a State of Flux and How to Meet These Challenges with Effective Strategies in the Near to MediumTerm?
NIHR Centre for Patient Safety & Service Quality (CPSSQ) annual conference (London)
Talk entitled Economic Analysis in Patient Safety
Monocle Radio, The Globalist (episode 793)
Series on big ideas shaping the world:healthcare innovation
et al., The Search for the Holy Grail -- Frugal Innovation in Healthcare from Developing Countries for Reverse Innovation to Developed Countries, Bmj Innovations, ISSN:2055-642X
et al., Global Lessons In Frugal Innovation To Improve Health Care Delivery In The United States, Health Affairs, ISSN:0278-2715
et al., 2017, Systematic review of economic analyses in patient safety: a protocol designed to measure development in the scope and quality of evidence., Bmj Open, Vol:7
et al., 2017, An evaluation of the quality of evidence available to inform current bone conducting hearing device national policy, Clinical Otolaryngology, Vol:42, ISSN:1749-4478, Pages:1000-1024
et al., 2017, Estimating the incidence and the economic burden of third and fourth-degree obstetric tears in the English NHS: an observational study using propensity score matching, Bmj Open, Vol:7, ISSN:2044-6055